Mobile Site ›

Chronic Lymphocytic Leukemia

New Approaches for a Common Disease



Goals Today

Slide 32

October 2008

Our goals today were to distinguish Chronic Lymphocytic Leukemia (CLL) from other B-cell chronic lymphoproliferative disorders, to understand the definition of the term monoclonal B-cell lymphocytosis (MBL), and to realize the issues associated with minimal residual disease (MRD) detection in CLL. Hopefully we have been able to achieve these objectives with you. I look forward to discussing risk stratification in CLL and the role of the clinical laboratory in a future Hot Topic with you.

Goals Today

 


Jump to section:


Key